100% patients receive onsite diabetic eye screening and 95% has instant AI results without dilation... this performance is only possible with the proven #EyeArt AI technology. x.com/EyenukInc/stat…

Nice article on major movers and shakers in the rapidly growing healthcare AI field. #artificialintelliegence #teleheath #fdacleared #eyeart Eyenuk, Inc. nanalyze.com/2021/02/ai-hea…

Excited to work with MaineHealth to leverage the FDA-cleared and Medicare-reimbursed #EyeArt autonomous AI technology! #CPT92229 #diabeticretinopathy #diabetesmanagement #populationhealth x.com/EyenukInc/stat…

We are glad that our FDA cleared and Medicare reimbursed #EyeArt AI system is contributing to healthcare access equality, as a free and charitable care clinic in Virginia chooses EyeArt to support its diabetic eye testing. x.com/EyenukInc/stat…

Very comprehensive review of AI in retina by Dr. Grayson Armstrong, a physician and surgeon at Massachusetts Eye and Ear and an instructor in ophthalmology at Harvard Medical School, Boston. x.com/EyenukInc/stat…

Welcome the newest customer for the EyeArt AI diabetic eye testing system... the University Hospital of New Jersey in Newark at its Emergency Department! x.com/EyenukInc/stat…

Eyenuk, Inc. is honored to be featured on NIH's website today as a national success story! NIH supported and guided us since day 1, which greatly fueled our continuous innovation. x.com/ncats_nih_gov/…

Congratulations to Eyenuk, Inc. clinical collaborators for a great presentation "Community Based eye screening by Armenian EyeCare Project". youtube.com/watch?v=eupyeX… #artificialintelligence #diabetes #diabeticretinopathy Armenian EyeCare

Insightful article by A. Paul Chous, MA, OD, FAAO optometrytimes.com/view/embrace-d…

Really looking forward to this webinar! Wagner Macula and Retina Center is not only a thought-leading group for retina disease management, but also a national leader for community eye screening. x.com/EyenukInc/stat…

Join this afternoon's webinar and learn how a private retina specialist practice grows business by leveraging FDA cleared AI technology in community eye screening. #retinaspecialist #ophthalmology #HEDIS #diabeticretinopathy #diabetes #optometry x.com/EyenukInc/stat…

Join this interesting webinar tomorrow to learn how @WorldDiabetesF funding and Eyenuk, Inc. AI technology significantly improved access to eye care in Armenia's low resource areas. x.com/EyenukInc/stat…

Look forward to panel discussion on Medicare/Medicaid reimbursement status for CPT 92229. Panel will include David B. Glasser, Michael X. Repka, and Kayla L. Amodeo from the American Academy of Ophthalmology, as well as Michael Beebe from ADVI Health. x.com/EyenukInc/stat…

Visit Eyenuk, Inc. virtual booth at #ADA2021 during June 25-29. x.com/EyenukInc/stat…

Excited to moderate the webinar today with American Academy of Ophthalmology experts to highlight latest reimbursement status for CPT 92229, the first #CPT code for an autonomous #AI technology. #Medicare, #Medicaid, and #HEDIS payment status will be discussed. x.com/EyenukInc/stat…

Welcome new investors led by @AXAIMAlts to the Eyenuk, Inc. team! Exciting growth is ahead of us. x.com/EyenukInc/stat…

Closing #HEDIS measurement gaps is important for all #healthplans. Eyenuk, Inc. is excited to partner with HCD International to support health plans with AI solutions for #diabetes eye testing. #NCQA #fivestars #artificialintelligence #92229 x.com/EyenukInc/stat…

Nice article based on #EyeArt UK study published by Ophthalmology at BMJ. #artificialintelligence #diabeticretinopathy #nhsuk endocrinologyadvisor.com/home/topics/di…

Check out my latest article: Eyenuk Applauds CMS CY 2022 Medicare Physician Fee Schedule Final Rule to Establish National Price for Autonomous AI Technology linkedin.com/pulse/eyenuk-a… via LinkedIn

Great to see that JAMA Network Open tweet on Eyenuk, Inc. pivotal trial results for #EyeArt (96% sensitivity for detection of more than mild diabetic retinopathy, and 97% sensitivity for vision-threatening diabetic retinopathy). x.com/JAMANetworkOpe…